Encore Dermatology Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Encore Dermatology Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11001
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Encore Dermatology Inc (Encore Dermatology) is a specialty dermatology company, which develops and commercializes novel prescription medicines and medical devices for the treatment of topical dermatological disorders. The company’s products include HylatopicPlus lotion, a combination of various ingredients, and Tetrix cream, a non-steroidal cream, for the relief of burning, itching and pain associated with various types of dermatoses, including atopic dermatitis, allergic contact dermatitis and radiation dermatitis, besides the moisturization of dry and waxy skin; and Tridesilon (desonide) cream, a synthetic corticosteroid for the relief of inflammation and pruritus caused by dermatoses. Encore Dermatology is headquartered in Malvern, Pennsylvania, the US.

Encore Dermatology Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Encore Dermatology Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Encore Dermatology Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Encore Dermatology Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Encore Dermatology Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Encore Dermatology Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Encore Dermatology Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Encore Dermatology Raises USD34 Million in Venture Financing 10
Encore Dermatology Raises USD12 Million in Venture Financing 11
Encore Dermatology Raises USD10.7 Million in Venture Financing 12
Licensing Agreements 13
Encore Dermatology Enters into Licensing Agreement with Promius Pharma 13
Encore Dermatology Inc – Key Competitors 14
Encore Dermatology Inc – Key Employees 15
Encore Dermatology Inc – Locations And Subsidiaries 16
Head Office 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Encore Dermatology Inc, Pharmaceuticals & Healthcare, Key Facts 2
Encore Dermatology Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Encore Dermatology Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Encore Dermatology Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Encore Dermatology Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Encore Dermatology Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Encore Dermatology Raises USD34 Million in Venture Financing 10
Encore Dermatology Raises USD12 Million in Venture Financing 11
Encore Dermatology Raises USD10.7 Million in Venture Financing 12
Encore Dermatology Enters into Licensing Agreement with Promius Pharma 13
Encore Dermatology Inc, Key Competitors 14
Encore Dermatology Inc, Key Employees 15

List of Figures
Encore Dermatology Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Encore Dermatology Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Encore Dermatology Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Encore Dermatology Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Encore Dermatology Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Encore Dermatology Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Encore Dermatology Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Encore Dermatology Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Encore Dermatology Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Alaska Air Group, Inc.:戦略・SWOT・企業財務分析
    Alaska Air Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary Alaska Air Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • SilverSun Technologies Inc (SSNT):企業の財務・戦略的SWOT分析
    Summary SilverSun Technologies Inc (SilverSun) is a technology company that offers transformational business technology solutions and services for manufacturers and distributors. The company’s ERP software products comprise ERP X3, MAS90 and MAS200. It offers network services such as 24/7 remote net …
  • Cross Country Healthcare Inc (CCRN):企業の財務・戦略的SWOT分析
    Cross Country Healthcare Inc (CCRN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • DCP Midstream Partners, LP:企業の戦略・SWOT・財務情報
    DCP Midstream Partners, LP - Strategy, SWOT and Corporate Finance Report Summary DCP Midstream Partners, LP - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Crocs Inc (CROX):企業の財務・戦略的SWOT分析
    Crocs Inc (CROX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • AusNet Services Ltd (AST)-エネルギー分野:企業M&A・提携分析
    Summary AusNet Services Ltd (AusNet) is a diversified energy network business entity that transmits and distributes power. It owns and manages electricity transmission network in Victoria; and delivers electricity to various customer connection points in eastern Victoria including Melbourne’s outer …
  • CellaVision AB (CEVI):企業の財務・戦略的SWOT分析
    CellaVision AB (CEVI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • TIBCO Software, Inc.:企業の戦略・SWOT・財務分析
    TIBCO Software, Inc. - Strategy, SWOT and Corporate Finance Report Summary TIBCO Software, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • CAB Incorporated:企業の戦略的SWOT分析
    CAB Incorporated - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • El Paso Electric Company:発電所・企業SWOT分析
    El Paso Electric Company - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key empl …
  • Genesis Energy:企業の戦略・SWOT・財務情報
    Genesis Energy - Strategy, SWOT and Corporate Finance Report Summary Genesis Energy - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Bio-Path Holdings Inc (BPTH):企業の財務・戦略的SWOT分析
    Summary Bio-Path Holdings Inc (Bio-Path) is a clinical stage biotechnology company that develops targeted therapies for acute myeloid leukemia (AML), chronic myeloid leukemia (CML) and other challenging cancers. The company provides products pipeline such as prexigebersen (Liposomal Grb2 Antisense) …
  • MiMedx Group Inc (MDXG)-医療機器分野:企業M&A・提携分析
    Summary MiMedx Group Inc (MiMedx) is a provider of bioactive healing products for tissue regeneration. The company’s products are used in the therapeutic areas of chronic wounds, dental, ophthalmology, spine, orthopedic surgery, sports medicine and urology. Its products help in reducing inflammation …
  • Polar Power Inc (POLA):企業の財務・戦略的SWOT分析
    Polar Power Inc (POLA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Eastern Company SAE:企業の戦略・SWOT・財務分析
    Eastern Company SAE - Strategy, SWOT and Corporate Finance Report Summary Eastern Company SAE - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Coretex Products, Inc.:企業の戦略・SWOT・財務情報
    Coretex Products, Inc. - Strategy, SWOT and Corporate Finance Report Summary Coretex Products, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • CyrusOne Inc:企業のM&A・事業提携・投資動向
    CyrusOne Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's CyrusOne Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, …
  • GAIL (India) Ltd (GAIL)-石油・ガス分野:企業M&A・提携分析
    Summary GAIL (India) Ltd (GAIL) is a vertically integrated gas company that carries out exploration and production, transmission of natural gas. It also has presence in petrochemical, liquid hydrocarbons and power and renewable sectors. GAIL is also a major LPG transmission company, besides managing …
  • Qatar Fuel (WOQOD) Q.S.C. (QFLS):企業の財務・戦略的SWOT分析
    Qatar Fuel (WOQOD) Q.S.C. (QFLS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • MediWound Ltd (MDWD):製薬・医療:M&Aディール及び事業提携情報
    Summary MediWound Ltd (MediWound) is a biopharmaceutical company that on develops, manufactures and commercializes novel therapeutics based on its patented proteolytic enzyme technology. Its products address unmet needs in the areas of severe burns, chronic and other hard-to-heal wounds.The company’ …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆